5
Views
102
CrossRef citations to date
0
Altmetric
Research Article

Tissue Transglutaminase-Dependent Posttranslational Modification of the Retinoblastoma Gene Product in Promonocytic Cells Undergoing Apoptosis

, , , , , , , & show all
Pages 6040-6048 | Received 14 Apr 1997, Accepted 13 Jun 1997, Published online: 29 Mar 2023

REFERENCES

  • Almasan, A., Y. Yin, R. E. K. Lee, A. Bradley, W. Li, J. R. Bertino, and G. M. Wahl. 1995. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA 92:5436–5440.
  • Amendola, A., M.-L. Gougeon, F. Poccia, A. Bondurand, L. Fesus, and M. Piacentini. 1996. Induction of “tissue” transglutaminase in HIV-pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues. Proc. Natl. Acad. Sci. USA 93:11057–11062.
  • Arends, M. J., and A. H. Wyllie. 1991. Apoptosis. Mechanism and role in pathology. Int. Rev. Exp. Pathol. 32:223–254.
  • Ballesteras, E., C. Abad, and L. Franco. 1996. Core histones are glutaminyl substrates for tissue transglutaminase. J. Biol. Chem. 271:18817–18824.
  • Bing, A., and Q. P. Dou. 1996. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1b-converting enzyme-like protease as candidate. Cancer Res. 56:438–442.
  • Bruns, R. F., F. D. Miller, R. L. Merruman, J. J. Howbert, W. H. Heath, E. Kobayashi, I. Takahashi, T. Tamaoki, and H. Nakano. 1991. Inhibition of protein kinase C by calphostin C is light-dependent. Biochem. Biophys. Res. Commun. 176:288–293.
  • DeCaprio, J. A., J. W. Ludlow, L. Dennis, Y. Furukawa, J. Griffin, S. Piwnica-Worms, H. Huang, and D. M. Livingstone. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085–1095.
  • Ellis, R. E., J. Yuan, and H. R. Horvitz. 1991. Mechanism and functions of cell death. Annu. Rev. Cell Biol. 7:663–698.
  • Fesus, L., and G. Arato. 1986. Quantitation of tissue transglutaminase by a sandwich ELISA system. J. Immunol. Methods 94:131–138.
  • Fesus, L., V. Thomazy, and A. Falus. 1987. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224:104–108.
  • Fesus, L., V. Thomazy, F. Autuori, M. P. Ceru, E. Tarcsa, and M. Piacentini. 1989. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett. 245:150–154.
  • Fesus, L., P. J. A. Davies, and M. Piacentini. 1991. Apoptosis: molecular mechanisms in programmed cell death. Eur. J. Cell Biol. 56:170–177.
  • Folk, J. E. 1980. Transglutaminases. Annu. Rev. Biochem. 49:517–531.
  • Gentile, V., V. Thomazy, M. Piacentini, L. Fesus, and P. J. A. Davies. 1992. Expression of tissue transglutaminase in BALB-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J. Cell Biol. 119:463–474.
  • Greenberg, C. S., P. J. Birckbichler, and R. H. Rice. 1992. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5:3071–3077.
  • Haas-Kogan, D. A., S. C. Kogan, D. Levi, P. A. Dazin T’Ang, Y.-K. T. Fung, and M. A. Israel. 1995. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:461–472.
  • Hale, A. J., C. A. Smith, L. C. Sutherland, V. E. A. Stoneman, V. L. Longthorne, A. C. Culhane, and G. T. Williams. 1996. Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236:1–26.
  • Hateboer, G., R. M. Kerkhoven, A. Shvarts, R. Bernards, and R. L. Beijersbergen. 1996. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev. 10:2960–2970.
  • Haupt, Y., S. Rowan, and M. Oren. 1995. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene 10:1563–1571.
  • Hofmann, F., F. Martelli, D. M. Livingston, and Z. Wang. 1996. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitinproteasome pathway. Genes Dev. 10:2949–2959.
  • Jacobson, M. D., J. F. Burne, and M. C. Raff. 1994. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13:1899–1910.
  • Janicke, R. U., P. A. Walker, X. Y. Lin, and A. G. Porter. 1996. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 15:6969–6978.
  • Jarvis, W. D., A. J. Turner, L. F. Povirk, R. S. Traylor, and S. Grant. 1994. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54:1707–1714.
  • Jones, T. L., and D. Lafrenz. 1992. Quantitative determination of the induction of apoptosis in a murine B cell line using flow cytometric bivariate cell cycle analysis. Cell. Immunol. 142:348–360.
  • Knight, C. R. L., D. Hand, M. Piacentini, and M. Griffin. 1993. Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis. Eur. J. Cell Biol. 60:210–217.
  • Koeffler, H. P., C. Miller, M. A. Nicolson, J. Ranyard, and R. A. Bosselman. 1986. Increased expression of p53 protein in human leukemia cells. Proc. Natl. Acad. Sci. USA 83:4035–4039.
  • Kumar, S., and M. F. Lavin. 1996. The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ. 3:255–268.
  • Leszczynski, D., Y. Zhao, M. Luokkamaki, and M. L. Foegh. 1994. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in the regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am. J. Pathol. 145:1265–1270.
  • Martel, C., E. Batsche, F. Harper, and C. Cremisi. 1996. Inactivation of retinoblastoma gene product RB or an RB-related protein by SV40 T antigen in MDCK epithelial cells results in massive apoptosis. Cell Death Differ. 3:285–298.
  • Melino, G., M. Annicchiarico-Petruzzelli, L. Piredda, E. Candi, V. Gentile, P. J. A. Davies, and M. Piacentini. 1994. “Tissue” transglutaminase and apoptosis: sense and antisense transfection studies in human neuroblastoma cells. Mol. Cell. Biol. 14:6584–6596.
  • Messmer, U. D., E. G. Lapetina, and B. Brüne. 1995. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol. Pharmacol. 47:757–765.
  • Morgenbesser, S. D., B. O. Williams, T. K. Jacks, and R. A. DePinho. 1994. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72–74.
  • Müller, R. 1995. Transcriptional regulation during the mammalian cell cycle. Trends Genet. 11:173–178.
  • Nakaoka, H., D. M. Perez, K. J. Baek, T. Das, A. Husain, K. Misono, M. Im, and R. M. Graham. 1994. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264:1593–1596.
  • Nemes, Z., R. Adany, M. Balazs, P. Boross, and L. Fesus. Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL60 and U937 cells undergoing apoptosis. J. Biol. Chem., in press.
  • Piacentini, M., C. Sartori, S. Beninati, A. M. Bargagli, and M. P. Argento-Ceru. 1986. Ornithine decarboxylase, transglutaminase, diamine oxidase and total diamines and polyamines in maternal liver and kidney throughout rat pregnancy. Biochem. J. 234:435–440.
  • Piacentini, M., N. Martinet, S. Beninati, and J. E. Folk. 1988. Free and protein-conjugated polyamines in mouse epidermal cells. J. Biol. Chem. 263:3790–3794.
  • Piacentini, M., F. Autuori, L. Dini, M. G. Farrace, L. Ghibelli, L. Piredda, and L. Fesus. 1991. “Tissue” transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factorstimulation. Cell Tissue Res. 263:227–235.
  • Piacentini, M., P. J. A. Davies, and L. Fesus. 1994. Transglutaminase in cells undergoing apoptosis, p. 143–163. In L. D. Tomei and F. O. Cope (ed.), Apoptosis: the molecular basis of apoptosis in disease. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  • Piacentini, M., L. Piredda, D. Starace, M. Annichiarico-Petruzzelli, M. Mattei, S. Oliverio, M. G. Farrace, and G. Melino. 1996. Differential growth of N- and S-type human neuroblastoma cells xenografted into SCID mice. Correlation with apoptosis. J. Pathol. 180:31–38.
  • Piredda, L., A. Amendola, V. Colizzi, P. J. A. Davies, M. G. Farrace, M. Fraziano, V. Gentile, I. Uray, M. Piacentini, and L. Fesus. 1997. Lack of “tissue” transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLlpr/lpr mice. Cell Death Differ. 4:463–472.
  • Slack, R. S., I. S. Skerjanc, B. Lach, J. Craig, K. Jardine, and M. W. McBurney. 1995. Cells differentiating into neuroectoderm undergo apoptosis in the absence of functional retinoblastoma family proteins. J. Cell Biol. 129:779–788.
  • Weinberg, R. A. 1995. The retinoblastoma product and cell cycle control. Cell 81:323–330.
  • White, E. 1994. p53, guardian of Rb. Nature 371:21–22.
  • Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602–3606.
  • Xu, H.-J., K. Xu, Y. Zhou, J. Li, W. F. Benedict, and S.-X. Hu. 1994. Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein. Proc. Natl. Acad. Sci. USA 91:9837–9841.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.